Affiliation
Department of Acute Medicine and Critical Care, The Christie, Manchester, UK.Issue Date
2020
Metadata
Show full item recordAbstract
Purpose of review: Emergency presentations in patients treated with immune checkpoint inhibitors (ICIs) are a clinical challenge. Clinicians need to be vigilant in diagnosing and treating immune-mediated toxicities. In this review, we consider the approach to managing an acutely unwell patient being treated with ICIs presenting as an emergency. Recent findings: A minority of acutely unwell patients treated with ICIs will have an immune-mediated toxicity. Early recognition and intervention in those with immune-mediated toxicity can reduce the duration and severity of the complications. The use of early immunosuppressive agents along corticosteroid therapy may improve outcomes in patients with life-threatening immune-mediated toxicity. Summary: Individualized management of immune-mediated toxicities is a key challenge for emergency oncology services; this has become part of routine cancer care.Citation
Cooksley T, Stutman R, Klotz A. Emergency management of immune-related toxicity. Curr Opin Oncol. 2020;32(4):274-81.Journal
Current Opinion in OncologyDOI
10.1097/cco.0000000000000635PubMed ID
32541313Additional Links
https://dx.doi.org/10.1097/cco.0000000000000635Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1097/cco.0000000000000635
Scopus Count
Collections
Related articles
- Adverse events associated with immune checkpoint inhibitor treatment for cancer.
- Authors: Esfahani K, Meti N, Miller WH Jr, Hudson M
- Issue date: 2019 Jan 14
- Atypical autoimmune adverse effects with checkpoint blockade therapies.
- Authors: Friedman CF, Snyder A
- Issue date: 2017 Feb 1
- Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review.
- Authors: Khoja L, Day D, Wei-Wu Chen T, Siu LL, Hansen AR
- Issue date: 2017 Oct 1
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.
- Authors: Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA, National Comprehensive Cancer Network
- Issue date: 2018 Jun 10
- Emergency presentations in patients treated with immune checkpoint inhibitors.
- Authors: Cooksley T, Gupta A, Al-Sayed T, Lorigan P
- Issue date: 2020 May